New-Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis-A Review

Overview

Journal Ther Apher Dial

Date 2019 Mar 12

PMID 30854792

Citations 4

Authors

Rajashri Yarragudi

Alois Gessl

Andreas Vychytil

Affiliations

Soon will be listed here.

Abstract

New-onset diabetes mellitus (NODM) is observed in both hemodialysis (HD) and peritoneal dialysis (PD) patients. The prevalence of NODM in dialysis patients is slightly higher compared to subjects of the general population. Based on currently published data there is no convincing evidence that the risk of NODM is different between HD and PD patients. Data on the effect of glucose load on risk of NODM in dialysis patients remain controversial. PD modality (automated or continuous ambulatory PD) has no significant influence on NODM incidence. Chronic inflammation is associated with NODM in dialysis patients. Reported differences in NODM between PD and HD patients are possibly also influenced by differences in demographic factors between these patient groups. Mortality in NODM patients is lower than mortality in patients with preexisting DM. This may be partly explained by the younger age and lower number of comorbidities in patients with NODM.

Citing Articles

Complications of Peritoneal Dialysis Part II: Nonmechanical Complications.

Cheng X, Bargman J Clin J Am Soc Nephrol. 2024; 19(6):791-799.

PMID: 38190143 PMC: 11168822. DOI: 10.2215/CJN.0000000000000418.

Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease.

Agarwal S, Gillis L, Wilkie M Clin J Am Soc Nephrol. 2024; 20(1):139-146.

PMID: 38190135 PMC: 11737450. DOI: 10.2215/CJN.0000000000000420.

Prognostic Value of Systemic Inflammatory Response Index for the Prognosis of Diabetic Maintenance Hemodialysis Patients: A Retrospective Observational Study.

Yan Z, Li L Int J Gen Med. 2023; 16:3613-3622.

PMID: 37637705 PMC: 10455827. DOI: 10.2147/IJGM.S425737.

Adipose and Plasma microRNAs miR-221 and 222 Associate with Obesity, Insulin Resistance, and New Onset Diabetes after Peritoneal Dialysis.

Chan G, Than W, Kwan B, Lai K, Chan R, Teoh J Nutrients. 2022; 14(22).

PMID: 36432575 PMC: 9699429. DOI: 10.3390/nu14224889.

The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years.

Than W, Ng J, Chan G, Fung W, Chow K, Szeto C Clin Kidney J. 2022; 15(1):70-78.

PMID: 35035938 PMC: 8757419. DOI: 10.1093/ckj/sfab139.

References

Rangel-Lopez A, Paniagua-Medina M, Urban-Reyes M, Cortes-Arredondo M, Alvarez-Aguilar C, Lopez-Meza J . Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study. Mutagenesis. 2013; 28(2):219-25. PMC: 3570793. DOI: 10.1093/mutage/ges075. View

Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2):137-49. DOI: 10.1016/j.diabres.2013.11.002. View

Li P, Culleton B, Ariza A, Do J, Johnson D, Sanabria M . Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol. 2013; 24(11):1889-900. PMC: 3810077. DOI: 10.1681/ASN.2012100987. View

Zanatta C, Crispim D, Sortica D, Klassmann L, Gross J, Gerchman F . Endothelin-1 gene polymorphisms and diabetic kidney disease in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2015; 7:103. PMC: 4653842. DOI: 10.1186/s13098-015-0093-5. View

Mehrotra R, Kopple J . Nutritional management of maintenance dialysis patients: why aren't we doing better?. Annu Rev Nutr. 2001; 21:343-79. DOI: 10.1146/annurev.nutr.21.1.343. View

Helmrich S, Ragland D, Leung R, Paffenbarger Jr R . Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991; 325(3):147-52. DOI: 10.1056/NEJM199107183250302. View

Mehrotra R, Kalantar-Zadeh K, Adler S . Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin?. Clin J Am Soc Nephrol. 2011; 6(7):1520-2. DOI: 10.2215/CJN.04210511. View

Paniagua R, Ventura M, Avila-Diaz M, Cisneros A, Vicente-Martinez M, Furlong M . Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009; 29(4):422-32. View

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

10.

Kobayashi H, Abe M, Yoshida Y, Suzuki H, Maruyama N, Okada K . Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis. Int J Mol Sci. 2016; 17(5). PMC: 4881445. DOI: 10.3390/ijms17050619. View

11.

. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996; 7(2):198-207. DOI: 10.1681/ASN.V72198. View

12.

Lameire N, Matthys D, Matthys E, Beheydt R . Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol. 1988; 30 Suppl 1:S53-8. View

13.

. Excerpts from the United States Renal Data Systems 2002 annual report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2003; 41(4 Suppl 2):v-ix, S7-254. DOI: 10.1016/s0272-6386(03)80001-x. View

14.

Silva L, Lopes A . 'Objective Score of Nutrition on Dialysis (OSND) as an alternative for the malnutrition-inflammation score in assessment of nutritional risk of haemodialysis patients'. Nephrol Dial Transplant. 2010; 25(9):3131-2. DOI: 10.1093/ndt/gfq364. View

15.

Shai I, Jiang R, Manson J, Stampfer M, Willett W, Colditz G . Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006; 29(7):1585-90. DOI: 10.2337/dc06-0057. View

16.

Ito H, Oshikiri K, Mifune M, Abe M, Antoku S, Takeuchi Y . The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus. J Diabetes Complications. 2012; 26(4):286-90. DOI: 10.1016/j.jdiacomp.2012.04.011. View

17.

Wang A, Brimble K, Brunier G, Holt S, Jha V, Johnson D . ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors. Perit Dial Int. 2015; 35(4):379-87. PMC: 4520720. DOI: 10.3747/pdi.2014.00279. View

18.

Hoshino J, Hamano T, Abe M, Hasegawa T, Wada A, Ubara Y . Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018; 33(7):1150-1158. DOI: 10.1093/ndt/gfy014. View

19.

Madziarska K, Weyde W, Krajewska M, Patrzalek D, Janczak D, Kusztal M . The increased risk of post-transplant diabetes mellitus in peritoneal dialysis-treated kidney allograft recipients. Nephrol Dial Transplant. 2010; 26(4):1396-401. DOI: 10.1093/ndt/gfq568. View

20.

Beberashvili I, Azar A, Sinuani I, Yasur H, Feldman L, Averbukh Z . Objective Score of Nutrition on Dialysis (OSND) as an alternative for the malnutrition-inflammation score in assessment of nutritional risk of haemodialysis patients. Nephrol Dial Transplant. 2010; 25(8):2662-71. DOI: 10.1093/ndt/gfq031. View